Different Immunohistochemical Expression of CTLA-4 in Diffuse Large B-Cell Lymphoma and Its Associated Prognostic Factors

Volume 26, Issue 2, February 2025, Pages 405-410

Liyona Rifani; Maria Francisca Ham; Dina Khoirunnisa; Agnes Stephanie Harahap

• View Article
• PDF 886.91 K

Immunohistochemical Expression of PD-L1 and CTLA-4 in Triple Negative Breast Cancer and Their Prognostic Associations

Volume 26, Issue 1, January 2025, Pages 319-326

Nehal Moaz Mehrez; Dina Abdallah Ibrahim; Maha Esmail El-Zaafarany; Dina A. El-Tantawy; Azza Abdel-Aziz

• View Article
• PDF 863.84 K

Prognostic Value of CD200 Expression and Soluble CTLA-4 Concentrations in Intermediate and High-Risk Myelodysplastic Syndrome Patients

Volume 21, Issue 8, August 2020, Pages 2225-2230

Salah Aref; Mohamed El Agdar; Ahmed El Sebaie; Tarek Abouzeid; Mohamed Sabry; Lamiaa Ibrahim

• View Article
• PDF 301.34 K

Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer

Volume 19, Issue 11, November 2018, Pages 3019-3025

Esmat Khalife; Ali Khodadadi; Abdolhosein Talaeizadeh; Leila Rahimian; Maryam Nemati; Abdollah Jafarzadeh

• View Article
• PDF 319 K

Lack of any Association of the CTLA-4 +49 G/A Polymorphism with Breast Cancer Risk in a North Indian Population

Volume 15, Issue 5, May 2014, Pages 2035-2038

• View Article
• PDF 331.11 K